February 24, 2026

Gossamer Bio reports topline Phase III PROSERA outcomes for PAH

​Gossamer Bio has reported topline data from the Phase III PROSERA study evaluating seralutinib in patients with PAH.The post Gossamer...

February 24, 2026

FDA approves Allurion’s PMA application for Gastric Balloon System

​Allurion has received the FDA clearance for PMA application for its Gastric Balloon System featuring the Allurion Smart Capsule for...

February 24, 2026

AbbVie announces $380m investment in North Chicago API facilities

​AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing facilities at its current...

February 23, 2026

Biocomposites to launch Synicem in UK for orthopaedic applications

​Biocomposites is set to launch its Synicem bone cement products in the UK with immediate effect for orthopaedic surgeries.The post...

February 23, 2026

J&J reports long-term QUASAR data for Tremfya in ulcerative colitis

​J&J has reported new findings from the QUASAR long-term extension study of Tremfya (guselkumab) for ulcerative colitis (UC).The post J&J...

February 23, 2026

Roche receives FDA acceptance for giredestrant combo NDA

​Roche has obtained acceptance from the US FDA for its NDA submitted for giredestrant, an oral therapy, along with everolimus...

February 20, 2026

AngioDynamics expands European indications for NanoKnife system 

​AngioDynamics has expanded indications across Europe for its NanoKnife System to include soft tissue ablation.The post AngioDynamics expands European indications...

February 20, 2026

Serina Therapeutics enrols first patient for SER-252 trial

​Serina Therapeutics has enrolled the first patient in its Phase Ib registrational trial of SER-252 for advanced Parkinson’s disease (PD).The...

February 20, 2026

Syngene and VivaMed collaborate on therapeutic programmes

​Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes.The post Syngene and VivaMed...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.